IS5198A - Ný efnasambönd - Google Patents

Ný efnasambönd

Info

Publication number: IS5198A
Authority: IS; Iceland
Prior art keywords: pct; date; new compounds; sec; pub
Prior art date: 1997-04-15

Application number

IS5198A

Other languages

English (en)

Inventor

Cheshire David

Cooper Martin

Donald David

Thorne Philip

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-15

Filing date

1999-09-27

Publication date

1999-09-27

1999-09-27 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

1999-09-27 Publication of IS5198A publication Critical patent/IS5198A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Virology (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)

IS5198A 1997-04-15 1999-09-27 Ný efnasambönd IS5198A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9701398A SE9701398D0 (sv)	1997-04-15	1997-04-15	Novel compounds
PCT/SE1998/000640 WO1998046606A1 (en)	1997-04-15	1998-04-07	Novel compounds

Publications (1)

Publication Number	Publication Date
IS5198A true IS5198A (is)	1999-09-27

Family

ID=20406576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5198A IS5198A (is)	1997-04-15	1999-09-27	Ný efnasambönd

Country Status (21)

Country	Link
US (1)	US6028074A (is)
EP (1)	EP0975636B1 (is)
JP (1)	JP2001520645A (is)
KR (1)	KR20010006350A (is)
CN (1)	CN1259951A (is)
AT (1)	ATE245648T1 (is)
AU (1)	AU733066B2 (is)
BR (1)	BR9808540A (is)
CA (1)	CA2286078A1 (is)
DE (1)	DE69816608T2 (is)
EE (1)	EE9900465A (is)
HU (1)	HUP0002104A3 (is)
ID (1)	ID22746A (is)
IL (1)	IL132153A0 (is)
IS (1)	IS5198A (is)
NO (1)	NO995006L (is)
PL (1)	PL336230A1 (is)
SE (1)	SE9701398D0 (is)
SK (1)	SK135699A3 (is)
TR (1)	TR199902538T2 (is)
WO (1)	WO1998046606A1 (is)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9801399D0 (sv)	1998-04-21	1998-04-21	Astra Pharma Prod	Method and apparatus for filling containers
GC0000177A (en)	1998-12-17	2006-03-29	Smithkline Beecham	Thrombopoietin mimetics
CY2010012I2 (el)	2000-05-25	2020-05-29	Novartis Ag	Μιμητικα θρομβοποιητινης
US6875786B2 (en)	2001-03-01	2005-04-05	Smithkline Beecham Corporation	Thrombopoietin mimetics
KR20040066788A (ko)	2001-08-31	2004-07-27	더 락커펠러 유니버시티	프스포다이에스터레이즈 활성 및 뇌에서프스포다이에스터레이즈 1ｂ 매개되는 신호의 조절
MY142390A (en)	2002-05-22	2010-11-30	Glaxosmithkline Llc	3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
TW200526638A (en)	2003-10-22	2005-08-16	Smithkline Beecham Corp	2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
EP1901701A4 (en) *	2005-05-24	2012-05-02	David M Ott	BODY CARE AND MEDICAL PRODUCTS WITH JOINED SULFUR ORGANIC GROUPS
CA2611312C (en)	2005-06-06	2013-12-03	Intra-Cellular Therapies, Inc.	Organic compounds
WO2007143705A2 (en) *	2006-06-06	2007-12-13	Intra-Cellular Therapies, Inc.	Organic compounds
ES2411604T3 (es)	2006-11-13	2013-07-05	Intra-Cellular Therapies, Inc.	Compuestos orgánicos
EP2089034A4 (en)	2006-12-05	2010-07-28	Intra Cellular Therapies Inc	NEW USES
ECSP077628A (es)	2007-05-03	2008-12-30	Smithkline Beechman Corp	Nueva composición farmacéutica
CN104402893A (zh)	2007-12-06	2015-03-11	武田药品工业株式会社	有机化合物
CA2707218A1 (en) *	2007-12-06	2009-06-11	Intra-Cellular Therapies, Inc.	Organic compounds
BRPI0922700A2 (pt)	2008-12-06	2015-08-11	Intracellular Therapies Inc	Compostos orgânicos
CN102238872A (zh)	2008-12-06	2011-11-09	细胞内治疗公司	有机化合物
JP5989993B2 (ja)	2008-12-06	2016-09-07	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
JP5813511B2 (ja)	2008-12-06	2015-11-17	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
WO2010065147A1 (en)	2008-12-06	2010-06-10	Intra-Cellular Therapies, Inc.	Organic compounds
MA32938B1 (fr)	2008-12-06	2012-01-02	Intra Cellular Therapies Inc	Composes organiques
WO2010098839A1 (en)	2009-02-25	2010-09-02	Intra-Cellular Therapies, Inc.	Pde 1 inhibitors for ophthalmic disorders
MX2011009821A (es)	2009-03-23	2012-01-25	Glenmark Pharmaceuticals Sa	Derivados de isotiazolo pirimidinadiona como moduladores del trpa1.
US8623880B2 (en)	2009-03-23	2014-01-07	Glenmark Pharmaceuticals S.A.	Fused pyrimidine-dione derivatives as TRPA1 modulators
EP2411393B1 (en)	2009-03-23	2014-01-22	Glenmark Pharmaceuticals S.A.	Fused pyrimidine-dione derivatives as trpa1 modulators
SI2411395T1 (sl)	2009-03-23	2013-07-31	Glenmark Pharmaceuticals S.A.	Furopirimidindionski derivati kot TRPA1 modulatorji
US9468637B2 (en)	2009-05-13	2016-10-18	Intra-Cellular Therapies, Inc.	Organic compounds
PL3127427T3 (pl)	2009-05-29	2020-06-15	Novartis Ag	Sposoby podawania związków agonistów trombopoetyny
SG178279A1 (en)	2009-08-05	2012-03-29	Intra Cellular Therapies Inc	Novel regulatory proteins and inhibitors
TW201206937A (en)	2010-05-31	2012-02-16	Intra Cellular Therapies Inc	Organic compounds
EP2590657A4 (en)	2010-05-31	2014-02-12	Intra Cellular Therapies Inc	ORGANIC CONNECTIONS
EP2576551A4 (en)	2010-05-31	2014-04-16	Intra Cellular Therapies Inc	ORGANIC CONNECTIONS
EP2575817A4 (en)	2010-05-31	2014-01-08	Intra Cellular Therapies Inc	ORGANIC CONNECTIONS
JP6051210B2 (ja)	2011-06-10	2016-12-27	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
AU2013273118B2 (en)	2012-06-08	2015-11-05	Glenmark Pharmaceuticals S.A.	Amides of 2-amino-4-arylthiazole compounds and their salts
EP2956141A4 (en)	2013-02-17	2016-10-26	Intra Cellular Therapies Inc	NEW USES
ES2717688T3 (es)	2013-03-15	2019-06-24	Intra Cellular Therapies Inc	Inhibidores de la PDE1 para uso en el tratamiento y/o prevención de lesiones de SNC, y enfermedades, trastornos o lesiones de SNP
ES2836129T3 (es)	2013-03-15	2021-06-24	Intra Cellular Therapies Inc	Compuestos orgánicos
EP3091983B1 (en)	2014-01-08	2019-10-02	Intra-Cellular Therapies, Inc.	Pharmaceutical compositions comprising a pde-1 inhibitor and a pde-2 inhibitor
US9884872B2 (en)	2014-06-20	2018-02-06	Intra-Cellular Therapies, Inc.	Organic compounds
US9546175B2 (en)	2014-08-07	2017-01-17	Intra-Cellular Therapies, Inc.	Organic compounds
US10285992B2 (en)	2014-08-07	2019-05-14	Intra-Cellular Therapies, Inc.	Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
US10131671B2 (en)	2014-08-07	2018-11-20	Intra-Cellular Therapies, Inc.	Organic compounds
KR102332957B1 (ko)	2014-09-17	2021-11-29	인트라-셀룰라 써래피스, 인코퍼레이티드.	화합물 및 방법
RU2709786C2 (ru)	2014-12-06	2019-12-20	Интра-Селлулар Терапиз, Инк.	Органические соединения
CN107205993B (zh)	2014-12-06	2021-03-09	细胞内治疗公司	有机化合物
WO2017172795A1 (en)	2016-03-28	2017-10-05	Intra-Cellular Therapies, Inc.	Novel compositions and methods
WO2018015088A1 (en) *	2016-06-23	2018-01-25	F. Hoffmann-La Roche Ag	Novel [1,2,31triazolo[4,5-d]pyrimidine derivatives
WO2018049417A1 (en)	2016-09-12	2018-03-15	Intra-Cellular Therapies, Inc.	Novel uses
US11839614B2 (en)	2018-01-31	2023-12-12	Intra-Cellular Therapies, Inc.	Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A2 signaling and/or adenosine A2 receptor expression
JP7612672B2 (ja)	2019-09-03	2025-01-14	イントラ－セルラー・セラピーズ・インコーポレイテッド	新規化合物
US12364695B2 (en)	2020-06-02	2025-07-22	Intra-Cellular Therapies, Inc.	Methods of treating inflammatory disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1982003626A1 (en) *	1981-04-22	1982-10-28	Gauri Kailash Kumar	New derivatives of pyrazolo(3,4-d)pyrimidine,preparation method thereof and remedy containing them
US4603203A (en) *	1983-12-14	1986-07-29	Takeda Chemical Industries, Ltd.	3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof
EP0237289A3 (en) *	1986-03-14	1988-07-27	Takeda Chemical Industries, Ltd.	Pyrazolo [3,4-d] pyrimidine derivatives, their production and use
TW370529B (en) *	1992-12-17	1999-09-21	Pfizer	Pyrazolopyrimidines
DE69323212T2 (de) *	1992-12-17	1999-05-27	Pfizer Inc., New York, N.Y.	Pyrazole mit crf antagonistischer aktivität

1997
- 1997-04-15 SE SE9701398A patent/SE9701398D0/xx unknown
1998
- 1998-04-07 WO PCT/SE1998/000640 patent/WO1998046606A1/en not_active Ceased
- 1998-04-07 TR TR1999/02538T patent/TR199902538T2/xx unknown
- 1998-04-07 IL IL13215398A patent/IL132153A0/xx unknown
- 1998-04-07 AT AT98917859T patent/ATE245648T1/de not_active IP Right Cessation
- 1998-04-07 ID IDW991207A patent/ID22746A/id unknown
- 1998-04-07 CN CN98806075A patent/CN1259951A/zh active Pending
- 1998-04-07 PL PL98336230A patent/PL336230A1/xx unknown
- 1998-04-07 BR BR9808540-9A patent/BR9808540A/pt not_active IP Right Cessation
- 1998-04-07 HU HU0002104A patent/HUP0002104A3/hu unknown
- 1998-04-07 CA CA002286078A patent/CA2286078A1/en not_active Abandoned
- 1998-04-07 AU AU70909/98A patent/AU733066B2/en not_active Ceased
- 1998-04-07 SK SK1356-99A patent/SK135699A3/sk unknown
- 1998-04-07 JP JP54380398A patent/JP2001520645A/ja not_active Ceased
- 1998-04-07 DE DE69816608T patent/DE69816608T2/de not_active Expired - Fee Related
- 1998-04-07 EP EP98917859A patent/EP0975636B1/en not_active Expired - Lifetime
- 1998-04-07 KR KR1019997009435A patent/KR20010006350A/ko not_active Withdrawn
- 1998-04-07 EE EEP199900465A patent/EE9900465A/xx unknown
- 1998-08-07 US US09/068,304 patent/US6028074A/en not_active Expired - Fee Related
1999
- 1999-09-27 IS IS5198A patent/IS5198A/is unknown
- 1999-10-14 NO NO995006A patent/NO995006L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2001520645A (ja)	2001-10-30
HUP0002104A3 (en)	2002-03-28
EP0975636A1 (en)	2000-02-02
EE9900465A (et)	2000-04-17
DE69816608D1 (de)	2003-08-28
SK135699A3 (en)	2000-05-16
WO1998046606A1 (en)	1998-10-22
AU733066B2 (en)	2001-05-03
CA2286078A1 (en)	1998-10-22
IL132153A0 (en)	2001-03-19
TR199902538T2 (xx)	2000-02-21
AU7090998A (en)	1998-11-11
HUP0002104A2 (hu)	2001-01-29
NO995006D0 (no)	1999-10-14
DE69816608T2 (de)	2004-04-15
PL336230A1 (en)	2000-06-19
ATE245648T1 (de)	2003-08-15
ID22746A (id)	1999-12-09
US6028074A (en)	2000-02-22
SE9701398D0 (sv)	1997-04-15
KR20010006350A (ko)	2001-01-26
CN1259951A (zh)	2000-07-12
BR9808540A (pt)	2000-05-23
NO995006L (no)	1999-10-14
EP0975636B1 (en)	2003-07-23

Publication	Publication Date	Title
EE9900465A (et)	2000-04-17	Uued ühendid
EE200000318A (et)	2001-08-15	Uudsed ühendid
EE9900539A (et)	2000-06-15	Uued ühendid
EE9900315A (et)	2000-02-15	Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitena
ATE334668T1 (de)	2006-08-15	Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
SE9702772D0 (sv)	1997-07-22	Novel compounds
HUT75776A (en)	1997-05-28	Pyrazolo and pyrrolopyridines, their using, pharmaceutical compositions containing them and intermediates
MXPA04003668A (es)	2004-07-22	Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
HUP0002346A1 (hu)	2001-05-28	Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
ATE251162T1 (de)	2003-10-15	Triazolo(4,5-d)pyrimidin-verbindungen
AU3862997A (en)	1998-02-20	Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
YU87501A (sh)	2004-05-12	Farmaceutski kompleksi
DE69804766D1 (de)	2002-05-16	Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AU7436098A (en)	1998-11-13	Use of mizolastine for preparing a medicine for treating inflammation